Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on March 8, 2021. The registrant is incorporated in Delaware and maintains its principal executive offices in Nashville, Tennessee. The report primarily serves to disclose a corporate presentation used by management at investor conferences.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The report focuses on the dissemination of non-filed information via an attached exhibit.
Guidance, Outlook, and Risks
Item 7.01 discloses a corporate presentation (Exhibit 99.1) dated March 2021. The filing explicitly states that the information contained in this presentation is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless specifically referenced. Consequently, specific guidance, outlook, or risk factors are not detailed within the body of this 8-K.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Corporate Presentation) for the actual content regarding company strategy and outlook, noting it is not legally "filed" information.
- Verify the trading symbol HROW on The NASDAQ Global Market.
- Confirm that no financial data is included in this specific 8-K text; refer to the most recent 10-K or 10-Q for audited financials.
- Note the Chief Financial Officer, Andrew R. Boll, signed the report on behalf of the company.